Industry Leaders to Present Evidence on the Impact of Blood Viscosity on Cardiovascular Health.Business Editors/Health & Medical Writers Scientific Advisory Summit EXTON, Pa.--(BW HealthWire)--March 13, 2002 Rheologics and the ACRI to Host Scientific Advisory Summit Discussing the Links Between Blood Viscosity and Cardiovascular Diseases Rheologics, Inc., a pioneer in the prevention and treatment of heart disease and stroke, today announced details of its symposium on blood viscosity, to be held March 16 in Atlanta. Hosted by the renowned Atlanta Cardiovascular Research Institute (ACRI), this conference gathers world leading cardiologists and rheologists to examine and discuss the association between blood viscosity and shear stress shear stress n. See shear. shear stress A form of stress that subjects an object to which force is applied to skew, tending to cause shear strain. , and the potential impact of elevated blood viscosity as a cardiovascular risk factor. Among the long list of medical experts presenting are Robert Rosenson, M.D., from Northwestern University Northwestern University, mainly at Evanston, Ill.; coeducational; chartered 1851, opened 1855 by Methodists. In 1873 it absorbed Evanston College for Ladies. in Chicago, who will outline the epidemiological association between whole blood viscosity and cardiovascular disease, and Wolfgang Koenig, M.D., from University of Ulm The University of Ulm (German: Universität Ulm) is a public university in the city of Ulm, in the South German state of Baden-Württemberg. The university was founded in 1967 and focuses on natural sciences, medicine and the engineering sciences, mathematics/ economics and Medical Center in Germany, who will discuss the relationship of cardiovascular risk factors to blood viscosity. "Rheologics has been working for several years with the development of a method for determining the viscosity profile of whole blood within the entire physiological range of shear stress experienced during the cardiac cycle cardiac cycle n. A complete beat of the heart, including systole and diastole and the intervals between, beginning with any event in the heart's action to the moment when that same event is repeated. ," noted Kenneth R. Kensey, M.D., Rheologics' founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "We are very pleased to have gained the mindshare of these veteran doctors and look forward to the fruitful discussions that will unfold." Additional subject areas include how viscosity relates to atherogenesis atherogenesis /ath·ero·gen·e·sis/ (-jen´e-sis) formation of atheromatous lesions in arterial walls.atherogen´ic ath·er·o·gen·e·sis n. , the relationship of viscosity to the pathogenesis of atherosclerosis and vulnerable plaque A vulnerable plaque is an atheromatous plaque which is particularly prone to produce sudden major problems, such as a heart attack or stroke. Generally an atheroma becomes vulnerable if it grows more rapidly and has a thin cover separating it from the bloodstream inside the , testing methodologies and the role of viscosity in congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. . For more information, or if you would like to schedule an interview with the doctors serving as symposium spokespersons, please contact K.C. Du Fay at 415/749-6550 or kcdufay@sterlingpr.com. The Scientific Advisory Summit takes place prior to the American College American College is the name of:
About ACRI The mission of the Atlanta Cardiovascular Research Institute is to support, promote, and improve the comprehensive care of the cardiovascular patient by integrating preclinical and clinical research and by creating data management tools to facilitate quality medical care. In addition, ACRI provides educational programs for cardiovascular specialists, allied health personnel, and the lay public that are designed to enhance the understanding of cardiovascular disease and treatment regimens. For more information, please contact Farah Chapes at 678/728-1950, or visit the ACRI website at www.acri.com. About Rheologics, Inc. Since 1997, Rheologics has pioneered a new standard of care in the prevention and treatment of heart disease and stroke. Rheologics' mission is to supplement the existing understanding of the risk factors for these diseases by focusing on the emerging field of hemorheology -- the study of the dynamics of blood flow and its impact on vascular-related diseases. The company's breakthrough product, the Kensey Rheolog(TM)(1), is the industry's first easy-to-use device for measuring the biophysical properties of unadulterated un·a·dul·ter·at·ed adj. 1. Not mingled or diluted with extraneous matter; pure. See Synonyms at pure. 2. Out-and-out; utter: the unadulterated truth. , circulating whole blood. With the acquisition of Cytometrics Inc. in 2001, Rheologics can offer non-invasive cell imaging technology through the CYTOSCAN(TM), allowing physicians to better monitor post-surgical disease states. Both devices are used at the patient point-of-care and will aid in the development of new therapies and diagnostic capabilities for a variety of disease states. The company is headquartered in Exton, Pa. For more information, please call 800/969-2585 or visit the company web site at www.rheologics.com. (1) The Kensey Rheolog is an IDE exempt device and is not approved by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for therapeutic and diagnostic use. The device is currently used by leading institutions for research purposes. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion